Bridgeway Capital Management, LLC Cabaletta Bio, Inc. Transaction History

Bridgeway Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$12.21 - $23.36 $56,166 - $107,456	-4,600 Reduced 9.09%	46,021 $1.04 Million
Q2 2023 Aug 14, 2023	SELL	$7.65 - $13.95 $958,774 - $1.75 Million	-125,330 Reduced 71.23%	50,621 $653,000
Q4 2022 Feb 14, 2023	SELL	$0.64 - $9.3 $32,000 - $465,000	-50,000 Reduced 22.13%	175,951 $1.63 Million
Q3 2022 Nov 14, 2022	SELL	$0.63 - $2.05 $18,018 - $58,632	-28,601 Reduced 11.24%	225,951 $147,000
Q2 2022 Aug 15, 2022	BUY	$0.99 - $2.11 $130,899 - $278,988	132,222 Added 108.09%	254,552 $270,000
Q1 2022 May 16, 2022	BUY	$1.68 - $3.92 $205,514 - $479,533	122,330 New	122,330 $248,000
Q2 2021 Aug 16, 2021	SELL	$7.2 - $11.73 $252,000 - $410,550	-35,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$10.39 - $14.53 $363,650 - $508,550	35,000 New	35,000 $389,000

126

47.9M

202K

110K

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $66.4M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.